Ductal adenocarcinoma of pancreas

• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Pending
  2025-523232-39-00 1 "Advanced Solid Tumors"
• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 304) Pending
  2025-523495-23-00 5 "Resected Pancreatic Ductal Adenocarcinoma (PDAC)"
• A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043) Recruiting
  2025-524160-38-00 5 2026-05-12 "Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI-H/dMM"
• AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors Recruiting
  2025-521707-48-00 1 2025-11-26 "KRAS Altered Advanced or Metastatic Solid Tumors"
• A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of … Recruiting
  2023-504254-35-00 7 2023-06-20 "Unresectable locally advanced or metastatic solid tumors: • "
• A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and s … Recruiting
  2025-521702-18-00 1 2026-05-21 "Locally advanced unresectable or metastatic colorectal cance"
• Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in pati … Recruiting
  2023-510356-23-00 1 2025-07-18 "Locally advanced or metastatic unresectable colorectal cance"
• RR001, a cell-based gene therapy administered in combination with chemotherapy for the treatment of patients with locally advanced pancreati … Recruiting
  2024-516019-26-00 7 2025-06-25
• A Phase 1a/b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of PRMT5 I … Recruiting
  2024-515307-19-00 1 2025-03-24 "Advanced, or metastatic solid tumors with methylthioadenosin"
• A clinical study of MK-2870 alone or with other treatments to treat gastrointestinal cancers (MK-9999-02A) Recruiting
  2023-508703-21-00 9 2024-08-01 "Colorectal cancer (CRC), pancreatic ductal adenocarcinoma (P"
• AMG 193 in Combination with Other Therapies in Subjects with Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous … Recruitment ended
  2024-511195-33-00 3 2024-09-23 "Gastrointestinal tract, biliary tract, or pancreatic cancers"
• A phase 1/1b/2 study of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors. Recruitment ended
  2023-504363-17-00 7 2022-05-13 "Advanced MTAP-null solid tumors"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3 … Ended
  2023-505322-34-00 1 2024-01-08 "Advanced or metastatic solid tumors"
• C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended
  2024-517988-23-00 1 "KRAS mutated advanced solid tumors"

Showing 1–14 of 14 trials